搜尋結果
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 6 日前The Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 5 日前... Commission on Tuesday said it is challenging hundreds of alleged "junk" patents ...
Trade secret claim still viable despite disclosure in patent application
Reuters· 2 日前Courts have also consistently held that the same principle applies to information disclosed in a published patent ...
USPTO issues proposed rules on discretionary denials in post-grant trials
Reuters· 3 日前Inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB) are frequent components ...
US trade panel to probe GoPro's claims that Chinese firm violated its patents
Reuters· 4 日前The U.S. International Trade Commission said on Wednesday it was launching a trade ...
How previous investing mistakes are shaping my thinking on the latest stock gone wrong
CNBC· 7 小時前This dilemma comes up quite a bit these days when Director of Portfolio Analysis Jeff Marks and ...
Baidu ranks first in nation in AI patent applications
China Daily· 6 日前Chinese tech giant Baidu Inc ranked first in terms of artificial intelligence patent applications and ...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 5 日前Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 5 日前Annmarie Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 5 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...